Co-IP assays revealed that DNMT3a forms a complex with TET2 and HDAC2 in both sorafenibR and parental HCC cells with a slight increase in their interaction potential in sorafenibR cells (Fig. S5c and S5d). The gene discussed is DNMT3A; the disease is hepatocellular carcinoma.